252 related articles for article (PubMed ID: 23924448)
1. Anti-human leukocyte antigens and anti-major histocompatibility complex class I-related chain A antibody expression in kidney transplantation during a four-year follow-up.
He J; Li C; Yuan XN; Zhang JL; Li Y; Wei XD; Hou JQ
Chin Med J (Engl); 2013; 126(15):2815-20. PubMed ID: 23924448
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
[TBL] [Abstract][Full Text] [Related]
3. Association of de novo human leukocyte antigen and major histocompatibility complex class I chain-related gene-A antibodies and proteinuria with graft survival 5 years after renal transplantation.
Zhang LW; Peng ZG; Xian WH; Cui XQ; Sun HB; Li EG; Geng LN; Zhao P; Tian J
Transplant Proc; 2013 Nov; 45(9):3249-53. PubMed ID: 24182794
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients.
Seyhun Y; Ozdilli K; Oguz F; Karahan G; Onal E; Turkmen A; Eldegez U; Nane I; Çalişkan Y; Bakkaloglu H; Carin M
Transplant Proc; 2012; 44(6):1660-6. PubMed ID: 22841239
[TBL] [Abstract][Full Text] [Related]
5. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against MICA antigens and kidney-transplant rejection.
Zou Y; Stastny P; Süsal C; Döhler B; Opelz G
N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098
[TBL] [Abstract][Full Text] [Related]
7. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
[TBL] [Abstract][Full Text] [Related]
8. [Relationship of distribution frequency of HLA antigen/antibody and PIRCHE score with DSA production and AMR occurrence].
Zheng J; Kuang PD; Zhang Y; Zhao Q; He XL; Ding XM; Xue WJ
Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(12):901-906. PubMed ID: 30917438
[No Abstract] [Full Text] [Related]
9. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
10. Complement-fixing antibodies against denatured HLA and MICA antigens are associated with antibody mediated rejection.
Cai J; Terasaki PI; Zhu D; Lachmann N; Schönemann C; Everly MJ; Qing X
Exp Mol Pathol; 2016 Feb; 100(1):45-50. PubMed ID: 26615783
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of anti-HLA and anti-Major histocompatibility complex class I related chain A antibodies in living related renal donor transplantation.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Transplant Proc; 2007 Apr; 39(3):759-60. PubMed ID: 17445592
[TBL] [Abstract][Full Text] [Related]
12. Serum major-histocompatibility-complex class I-related chain A antibody detection for the evaluation of graft dysfunction in renal allograft recipients.
Zhang M; Lu FM; Qu LX; He J; Yuan XN; Gu Y
Chin Med J (Engl); 2011 Jul; 124(14):2127-31. PubMed ID: 21933614
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation.
Cox ST; Stephens HA; Fernando R; Karasu A; Harber M; Howie AJ; Powis S; Zou Y; Stastny P; Madrigal JA; Little AM
Hum Immunol; 2011 Oct; 72(10):827-34. PubMed ID: 21664940
[TBL] [Abstract][Full Text] [Related]
14. Donor non-specific MICA antibodies in renal transplant recipients.
Sapák M; Chreňová S; Tirpáková J; Žilinská Z; Ďurmanová V; Shawkatová I; Jakuš V; Kuba D; Buc M
Immunobiology; 2014 Feb; 219(2):109-12. PubMed ID: 24054943
[TBL] [Abstract][Full Text] [Related]
15. The effect of anti-human leukocyte antigen, anti-major histocompatibility complex class 1 chain-related antigen a, and anti-glutathione transferase-T1 antibodies on the long-term survival of renal allograft.
Akgul SU; Oğuz FS; Çalışkan Y; Kekik C; Çağatay P; Türkmen A; Nane I; Aydın F; Temurhan S
Transplant Proc; 2013 Apr; 45(3):890-4. PubMed ID: 23622580
[TBL] [Abstract][Full Text] [Related]
16. Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients.
Min JW; Lee H; Choi BS; Park CW; Yang CW; Kim YS; Choi YJ; Oh EJ; Chung BH
Ann Lab Med; 2018 Sep; 38(5):450-457. PubMed ID: 29797816
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of circulating antibodies in a renal transplantation population: preliminary results.
Rodríguez Ferrero ML; Arroyo D; Panizo N; Vicario JL; Balas A; Anaya F
Transplant Proc; 2012 Nov; 44(9):2548-50. PubMed ID: 23146450
[TBL] [Abstract][Full Text] [Related]
18. Posttransplant-Alloantibodies Against MICA Antigens Associated With Decreased Long-Term Allograft Survival of Kidney Transplant Recipients.
Ming Y; Peng B; Guo X; Luo W; Shao M; Cheng K; Luo Q; Zou Y
Transplant Proc; 2022 Sep; 54(7):1801-1808. PubMed ID: 36057454
[TBL] [Abstract][Full Text] [Related]
19. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
[TBL] [Abstract][Full Text] [Related]
20. Higher Serum Trough Levels of Tacrolimus Increase 5-Year Allograft Survival in Antibody Positive Renal Transplant Patients.
Peng ZG; Tian J
Clin Transpl; 2014; ():209-14. PubMed ID: 26281147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
